`
`Patent. No. 9,187,405
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX INC. and APOTEX CORR,
`
`Petitioners,
`
`v.
`
`NOVARTIS AG,
`
`Patent Owner.
`
`Case IPR2017-00854
`
`U. S. Patent No. 9,187,405
`
`POWER OF ATTORNEY PURSUANT TO § 42.1003)
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.-S. Patent and Trademark Office
`
`PO. Box 1450-
`
`- Alexandria, VA 22313-1450
`
`
`
`Case No. IPR2017-00854
`
`Patent No. 9,187,405
`
`Novartis AG and Novartis Pharmaceuticals Corporation hereby appoint Jane
`
`M. Love, PhD. (Reg. No. 42,812) and Robert W. Trenchard (pro hac vice to be
`
`filed), both of Gibson, Dunn & Crutcher LLP, as lead counsel and backup counsel,
`
`respectively, to represent Patent Owner, real party-in—interest Novartis AG in the
`
`inter partes review proceeding concerning US. Patent No. 9,187,405 before the
`
`Patent Trial and Appeal Board in the United States Patent and Trademark Office,
`
`and to transact all business connected therewith.
`
`Address all communications, emails, and telephone calls to lead and back up
`
`counsel, as listed below:
`
`Lead Counsel:
`
`Back-up Counsel:
`
`Robert W. Trenchard
`(pro hac vice to be filed)
`200 Park Avenue, 47th Floor
`New York, NY 10166
`Phone: (212) 351-3942
`Fax: (212) 351-5242
`rtrenchard@gibsondunn.com
`
`Jane M. Love, Ph.D.
`(Reg. No. 42,812)
`200 Park Avenue, 47th Floor
`New York, NY 10166
`Phone: (212) 351—3922
`Fax: (212) 35 1 -63 22
`'love
`ibsondunncom
`
`
`
`
`
`
`
`
`
`
`
`
`The undersigned individuals are authorized to sign this Power of Attorney
`
`on behalf of Patent Owner, real party-in-interest Novartis AG, and for Novartis
`
`Pharmaceuticals Corporation, respectively.
`
`
`
`FOR: NOVARTI
`
`Authorized Signatory
`
`FOR: NOVARTIS PHARMACEU
`
`LS CORPORATION
`
`Signature:
`
`(A
`
`Name: Rig/1&3 (giflgcé
`Authorized Signatory
`
`